In contrast, with aldosterone or L-NAME/AngII treatment, striatin deficiency did not modify aldosterone-mediated damage: in the heart and kidney, macrophage infiltration, and increases in aldosterone-induced biomarkers of injury. This evidence concerns the gene AGT and hyperinsulinemic hypoglycemia, familial, 4.